1
|
Saleem Z, Moore CE, Kalungia AC, Schellack N, Ogunleye O, Chigome A, Chowdhury K, Kitutu FE, Massele A, Ramdas N, Orubu ES, Cook A, Khuluza F, Zaranyika T, Funiciello E, Lorenzetti G, Nantamu M, Parajuli A, Kurdi A, Nabayiga H, Jairoun AA, Haque M, Campbell SM, Van Der Bergh D, Godman B, Sharland M. Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries. JAC Antimicrob Resist 2025; 7:dlaf033. [PMID: 40134815 PMCID: PMC11934068 DOI: 10.1093/jacamr/dlaf033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/27/2025] Open
Abstract
Background There are concerns globally with rising rates of antimicrobial resistance (AMR), particularly in low- and middle-income countries (LMICs). AMR is driven by high rates of inappropriate prescribing and dispensing of antibiotics, particularly Watch antibiotics. To develop future interventions, it is important to document current knowledge, attitudes and practices (KAP) among key stakeholder groups in LMICs. Methods We undertook a narrative review of published papers among four WHO Regions including African and Asian countries. Relevant papers were sourced from 2018 to 2024 and synthesized by key stakeholder group, country, WHO Region, income level and year. The findings were summarized to identify pertinent future activities for all key stakeholder groups. Results We sourced 459 papers, with a large number coming from Africa (42.7%). An appreciable number dealt with patients' KAP (33.1%), reflecting their influence on the prescribing and dispensing of antibiotics. There was marked consistency of findings among key stakeholder groups across the four WHO Regions, all showing concerns with high rates of prescribing of antibiotics for viral infections despite professed knowledge of antibiotics and AMR. There were similar issues among dispensers. Patients' beliefs regarding the effectiveness of antibiotics for self-limiting infectious diseases were a major challenge, although educational programmes did improve knowledge. The development of the AWaRe (Access, Watch and Reserve) system, including practical prescribing guidance, provides a future opportunity for the standardization of educational inputs. Conclusions Similar KAP regarding the prescribing and dispensing of antibiotics across LMICs and stakeholder groups presents clear opportunities for standardization of educational input and practical training programmes based on the AWaRe system.
Collapse
Affiliation(s)
- Zikria Saleem
- Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan
| | - Catrin E Moore
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
| | - Aubrey C Kalungia
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia
| | - Natalie Schellack
- Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria 0084, South Africa
| | - Olayinka Ogunleye
- Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos 100271, Nigeria
- Department of Medicine, Lagos State University Teaching Hospital, Ikeja 100271, Nigeria
| | - Audrey Chigome
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa
| | - Kona Chowdhury
- Department of Pediatrics, Gonoshasthaya Somaj Vittik Medical College, Dhaka 1344, Bangladesh
| | - Freddy Eric Kitutu
- Sustainable Pharmaceutical Systems (SPS) Unit, School of Health Sciences, Makerere University, PO Box 7072, Kampala, Uganda
- Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University, SE-751 85 Uppsala, Sweden
- Department of Pharmacy, Makerere University School of Health Sciences, Kampala, Uganda
| | - Amos Massele
- Department of Clinical Pharmacology and Therapeutics, Hurbert Kairuki Memorial University, 70 Chwaku Road Mikocheni, Dar Es Salaam P.O. Box 65300, Tanzania
| | - Nishana Ramdas
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa
| | - E Sam Orubu
- Department of Biomedical Engineering, Boston University College of Engineering, Boston, MA, USA
- Institute for Health System Innovation & Policy, Boston University, Boston, MA, USA
| | - Aislinn Cook
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
- Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford OX1 2JD, UK
| | - Felix Khuluza
- Pharmacy Department, Formerly College of Medicine, Kamuzu University of Health Sciences (KUHeS), Blantyre P.O. Box 278, Malawi
| | - Trust Zaranyika
- Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box MP167, Zimbabwe
| | - Elisa Funiciello
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
| | - Giulia Lorenzetti
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
| | - Miriam Nantamu
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
| | - Ayuska Parajuli
- HERD International, Lalitpur, Nepal
- Public Health Research Society, Kathmandu, Nepal
| | - Amanj Kurdi
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa
- Department of Clinical Pharmacy, College of Pharmacy, Hawler Medical University, Kurdistan Regional Governorate, Erbil, Iraq
- Strathclyde Institute of Pharmacy and Biomedical Science (SIPBS), University of Strathclyde, Glasgow G4 0RE, UK
- College of Pharmacy, Al-Kitab University, Kirkuk 36015, Iraq
| | - Hellen Nabayiga
- Management Science Department, Strathclyde Business School, University of Strathclyde, 199 Cathedral Street, Glasgow G4 0QU, UK
| | - Ammar Abdulrahman Jairoun
- Health and Safety Department, Dubai Municipality, Dubai, United Arab Emirates
- Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates
- Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman 346, United Arab Emirates
| | - Mainul Haque
- Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Sungai, Besi, 57000 Kuala Lumpur, Malaysia
- Karnavati Scientific Research Center, Karnavati School of Dentistry, Karnavati University, Gandhinagar 382 422, Gujarat, India
| | - Stephen M Campbell
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa
- School of Health Sciences, University of Manchester, Manchester, UK
| | - Dena Van Der Bergh
- Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
| | - Brian Godman
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa
- Strathclyde Institute of Pharmacy and Biomedical Science (SIPBS), University of Strathclyde, Glasgow G4 0RE, UK
- Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates
| | - Mike Sharland
- Centre for Neonatal and Paediatric Infection, Institute for Infection and Immunity, City St George’s, University of London, London SW17 0RE, UK
| |
Collapse
|
3
|
Mathew P, Chandy SJ, Sivaraman S, Ranjalkar J, Ali HM, Thomas SA. Formulating a Community-Centric Indicator Framework to Quantify One Health Drivers of Antibiotic Resistance: A Preliminary Step towards Fostering 'Antibiotic-Smart Communities'. Antibiotics (Basel) 2024; 13:63. [PMID: 38247622 PMCID: PMC10812418 DOI: 10.3390/antibiotics13010063] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Revised: 12/28/2023] [Accepted: 01/02/2024] [Indexed: 01/23/2024] Open
Abstract
Antibiotic resistance (ABR) is increasing the mortality and morbidity associated with infectious diseases, besides increasing the cost of healthcare, saturating health system capacity, and adversely affecting food security. Framing an appropriate narrative and engaging local communities through the 'One Health' approach is essential to complement top-down measures. However, the absence of objective criteria to measure the performance of ABR interventions in community settings makes it difficult to mobilize interest and investment for such interventions. An exercise was therefore carried out to develop an indicator framework for this purpose. A comprehensive list of indicators was developed from experiences gathered through community engagement work in a local panchayat (small administrative area) in Kerala, India and a consultative process with health, veterinary, environment, and development experts. A prioritization exercise was carried out by global experts on ABR, looking at appropriateness, feasibility, and validity. A 15-point indicator framework was designed based on the prioritization process. The final set of indicators covers human health, animal health, environment management, and Water Sanitation and Hygiene (WASH) domains. The indicator framework was piloted in the panchayat (located in Kerala), which attained a score of 34 (maximum 45). The score increased when interventions were implemented to mitigate the ABR drives, indicating that the framework is sensitive to change. The indicator framework was tested in four sites from three other Indian states with different socioeconomic and health profiles, yielding different scores. Those collecting the field data were able to use the framework with minimal training. It is hoped that, this indicator framework can help policymakers broadly understand the factors contributing to ABR and measure the performance of interventions they choose to implement in the community as part of National Action Plan on AMR.
Collapse
Affiliation(s)
- Philip Mathew
- ReAct Asia Pacific, Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore 632002, Tamil Nadu, India; (P.M.); (S.S.); (H.M.A.); (S.A.T.)
| | - Sujith J. Chandy
- Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore 632002, Tamil Nadu, India;
| | - Satya Sivaraman
- ReAct Asia Pacific, Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore 632002, Tamil Nadu, India; (P.M.); (S.S.); (H.M.A.); (S.A.T.)
| | - Jaya Ranjalkar
- ReAct Asia Pacific, Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore 632002, Tamil Nadu, India; (P.M.); (S.S.); (H.M.A.); (S.A.T.)
| | - Hyfa Mohammed Ali
- ReAct Asia Pacific, Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore 632002, Tamil Nadu, India; (P.M.); (S.S.); (H.M.A.); (S.A.T.)
| | - Shruthi Anna Thomas
- ReAct Asia Pacific, Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore 632002, Tamil Nadu, India; (P.M.); (S.S.); (H.M.A.); (S.A.T.)
| |
Collapse
|